Jeremy R.M. Haigh

A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis

G. Ochs, Richard D. Penn, Michelle M. York et al. · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · 2000 · 299 citations

Medicine, Neurology, Pharmacology +17

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

H‐G Eichler, LG Baird, Richard Barker et al. · Clinical Pharmacology & Therapeutics · 2015 · 187 citations · Full text

Pharmacy, Pharmaceutical Policy, Drug Approval Processes +15

Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients

Harold J.G.M. van Megen, H.G.M. Westenberg, Johan A. den Boer et al. · Psychopharmacology · 1994 · 110 citations

Medicine, Pharmacology, Psychiatry +12

Poor Compliance Is a Major Factor in Unstable Outpatient Control of Anticoagulant Therapy

Jeremy R.M. Haigh, Lesley E. Rhodes, S Peaker et al. · Thrombosis and Haemostasis · 1989 · 98 citations

Medicine, Pharmacology, Pharmacotherapy +13

Differences between the tolerance characteristics of two anticonvulsant benzodiazepines

J P Gent, M. Feely, Jeremy R.M. Haigh · Life Sciences · 1985 · 66 citations

Medicine, Pharmacology, Pharmacotherapy +10